su5402 Search Results


95
Tocris su5402
Su5402, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc04169698-164-13-17?v=Tocris
Average 95 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

95
Tocris chemical treatment
Chemical Treatment, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pm29291977-250-19-24?v=Tocris
Average 95 stars, based on 1 article reviews
chemical treatment - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

94
Selleck Chemicals su5402
Figure 1. TKIs rescue FGF2-mediated inhibition of chondrocyte proliferation. (A) RCS chondrocytes were treated with FGF2 and FGFR TKIs <t>SU5402,</t> PD173074, AZD1480, AZD4547 and BGJ398 as indicated, and cell numbers were determined by crystal violet staining 96 h later. Data represent averages for six wells. Results are
Su5402, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pm26494904-153-20-32?v=Selleck+Chemicals
Average 94 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology su5402
Figure 1. TKIs rescue FGF2-mediated inhibition of chondrocyte proliferation. (A) RCS chondrocytes were treated with FGF2 and FGFR TKIs <t>SU5402,</t> PD173074, AZD1480, AZD4547 and BGJ398 as indicated, and cell numbers were determined by crystal violet staining 96 h later. Data represent averages for six wells. Results are
Su5402, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc04589145-141-24-29?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc su5402
Figure 1. TKIs rescue FGF2-mediated inhibition of chondrocyte proliferation. (A) RCS chondrocytes were treated with FGF2 and FGFR TKIs <t>SU5402,</t> PD173074, AZD1480, AZD4547 and BGJ398 as indicated, and cell numbers were determined by crystal violet staining 96 h later. Data represent averages for six wells. Results are
Su5402, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc06811699-47-37-38?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
FUJIFILM su5402
Figure 1. TKIs rescue FGF2-mediated inhibition of chondrocyte proliferation. (A) RCS chondrocytes were treated with FGF2 and FGFR TKIs <t>SU5402,</t> PD173074, AZD1480, AZD4547 and BGJ398 as indicated, and cell numbers were determined by crystal violet staining 96 h later. Data represent averages for six wells. Results are
Su5402, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/bio_rxiv__2022__01__04__475010-324-4-6?v=FUJIFILM
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Merck KGaA vegf inhibitor su5416
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Vegf Inhibitor Su5416, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc09406997-70-24-28?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
vegf inhibitor su5416 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Pharmacia Upjohn LLC su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/10__1074_slash_jbc__m109__052290-54-36-37?v=Pharmacia+Upjohn+LLC
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
VASCO DRUG LABORATORIES su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by VASCO DRUG LABORATORIES, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pm15716343-110-0-16?v=VASCO+DRUG+LABORATORIES
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Stem Cell Sciences plc su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by Stem Cell Sciences plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc02735113-310-4-8?v=Stem+Cell+Sciences+plc
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Cayman Chemical su5406 cayman 131825
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5406 Cayman 131825, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc10639082-68-24-25?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
su5406 cayman 131825 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Microm International GmbH su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by Microm International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402/pmc03899817__supp_141__3__639_DEV098731-12-50-52?v=Microm+International+GmbH
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. TKIs rescue FGF2-mediated inhibition of chondrocyte proliferation. (A) RCS chondrocytes were treated with FGF2 and FGFR TKIs SU5402, PD173074, AZD1480, AZD4547 and BGJ398 as indicated, and cell numbers were determined by crystal violet staining 96 h later. Data represent averages for six wells. Results are

Journal: Human molecular genetics

Article Title: Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.

doi: 10.1093/hmg/ddv441

Figure Lengend Snippet: Figure 1. TKIs rescue FGF2-mediated inhibition of chondrocyte proliferation. (A) RCS chondrocytes were treated with FGF2 and FGFR TKIs SU5402, PD173074, AZD1480, AZD4547 and BGJ398 as indicated, and cell numbers were determined by crystal violet staining 96 h later. Data represent averages for six wells. Results are

Article Snippet: The chemicals were obtained from the following manufacturers: FGF2 and FGF22 (R&D Systems, Minneapolis, MN); heparin (Sigma-Aldrich, St. Louis, MO); SU5402 and PD173074 (Tocris Bioscience, Bristol, UK); and AZD1480, AZD4547 and BGJ398 (Selleckchem, Houston, TX).

Techniques: Inhibition, Staining

Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.

Journal: Current Issues in Molecular Biology

Article Title: Pro-Angiogenetic Effects of Purified Extracts from Helix aspersa during Zebrafish Development

doi: 10.3390/cimb44080232

Figure Lengend Snippet: Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods, and ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.

Article Snippet: Zebrafish embryos were then treated at 4 hpf with the snail derivatives LH, LM, LH3, and LM2, and then at 15 hpf with the VEGF inhibitor SU5416 (Sunitinib, Merck KGaA, Darmstadt, Germany) at a final concentration of 5 μg/mL in fish water and incubated in 3 cm diameter well-plates.

Techniques: Marker, Staining, Microscopy, Software